Kenneth BARTIZAL,Paul DARUWALA,David HUGHES,Martin Patrick HUGHES,Navdeep B. MALKAR,Balasingam RADHAKRISHNAN,Anuradha VAIDYA
申请号：
US16629711
公开号：
US20200268833A1
申请日:
2018.07.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
